New Directions in Monoclonal Antibodies: Technologies, Markets, Competition

New Directions in Monoclonal Antibodies: Technologies, Markets, Competition
CHA Advances Reports
October 1, 2004
185 Pages
Pub ID: CHI1080692
US $4,200.00 Online Download
US $2,750.00 Hard Copy Mail Delivery
US $3,500.00 PDF Email - Site License
Abstract
New Directions in Monoclonal Antibodies: Technologies, Markets, Competition reviews the broad drug development effort that is focused on bringing improved mAb-based products to the market, including those used for drug discovery research, in vivo diagnostics, and therapeutic applications.
This report examines the more than 110 mAb products currently in clinical trials, as well as the products that are already available and those still at the preclinical stage that are likely to play an important role in the advancement of the field.
The report presents further analysis to evaluate the market potential for monoclonal antibodies in development for a variety of diseases. It reviews some general observations concerning commercialization of mAbs, then addresses the major disease categories, including patient numbers for diseases of interest; competing therapeutics already on the market, particularly those that have recently gained regulatory approval; and, where available, estimates of market sizes in dollars. Only those conditions for which drug candidates have been identified or which have been prominently mentioned as potential markets by pharmaceutical companies in the field are covered.
Please Note: The cost of Instant Online Delivery for this report also includes a country license - this means that any of an organization's branches within the same country can access the data without an additional fee.
Comments: 0
Votes:29